ArticleCureus2021
High Incidence of Bronchospastic Response to a Stair Climbing Exercise.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background While it is increasingly recognized that exercise-induced bronchoconstriction (EIB) affects a substantial proportion of sport participants, the relation of EIB incidence and severity to the type and intensity of exertion remains under-investigated. The aim of this study was to establish the incidence and severity of EIB during a stair race, a highly demanding all-out effort exercise. We hypothesized that a large proportion of participants would develop EIB to this particular high-intensity competition, and that among the predisposing factors, severity of EIB would depend on the level of exertion. Methodology In this study, screening for EIB was conducted during the official competitive race to a 114-m skyscraper held during the late spring in a city center of approximately 0.5 million residents. Healthy active men (n = 26; age = 32.0 ± 7.0 years) volunteering for the study from the field of the race were included. Allergy Questionnaire for Athletes was completed, and responses of expiratory capacity (forced expiratory volume in the first second, FEV1) and blood lactate were measured by portable digital devices. Results On average, FEV1 dropped by 10.5 ± 5.6% after the exercise. In 11 (approximately 42.5%) participants, FEV1 drop was >10%, indicative of clinical EIB. While age, anthropometry, training experience, allergy history, baseline FEV1, and post-exercise lactate did not differ in responders versus non-responders, those with FEV1 decrement of >10% were slower in the race. Conclusions Due to very high incidence of EIB observed in active men performing a maximal-effort task and negative association of EIB with competitive performance, the condition of these individuals undertaking regular intense exercise deserves more attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.